ESC 365 - Cost impact and cost-effectiveness of ablation and device therapy compared to other medical therapies.

EHRA Premium Access

Cost impact and cost-effectiveness of ablation and device therapy compared to other medical therapies.

Session: Improving efficacy in the EP lab: work flow, process optimisation and economical balance

Topic: Policy initiative

Speaker: Professor F. Leyva (Birmingham, GB)

Event: EHRA EUROPACE - CARDIOSTIM 2017

Congress Presentation

Add to my library

About the speaker

Professor Francisco Leyva

Aston University, Birmingham (United Kingdom of Great Britain & Northern Ireland)

12 presentations

0 follower

2 more presentations in this session

The value of improved work flow: process optimization medicine.

Speaker: Doctor G. Trojandt (DE)

Understanding economics in EP: benchmarks, costs and reimbursement.

Speaker: Doctor C. Elsner (Luebeck, DE)

Access the full session

Improving efficacy in the EP lab: work flow, process optimisation and economical balance

Speakers: Professor F. Leyva, Doctor G. Trojandt, Doctor C. Elsner

About the event

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources